Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view
- PMID: 25741777
- DOI: 10.1139/cjpp-2014-0383
Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view
Abstract
Vitamin D3 is one of the few natural compounds that has, via its metabolite 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) and the transcription factor vitamin D receptor (VDR), a direct effect on gene regulation. For efficiently applying the therapeutic and disease-preventing potential of 1,25(OH)2D3 and its synthetic analogs, the key steps in vitamin D signaling need to be understood. These are the different types of molecular interactions with the VDR, such as (i) the complex formation of VDR with genomic DNA, (ii) the interaction of VDR with its partner transcription factors, (iii) the binding of 1,25(OH)2D3 or its synthetic analogs within the ligand-binding pocket of the VDR, and (iv) the resulting conformational change on the surface of the VDR leading to a change of the protein-protein interaction profile of the receptor with other proteins. This review will present the latest genome-wide insight into vitamin D signaling, and will discuss its therapeutic implications.
Keywords: VDR partner proteins; analogues de la vitamine D; chromatin immunoprecipitation; crystal structure; immunoprécipitation de chromatine; protéines partenaires du VDR; signalisation de la vitamine D in vivo; structure cristalline; vitamin D; vitamin D analogs; vitamin D signaling in vivo; vitamine D.
Similar articles
-
Molecular endocrinology of vitamin D on the epigenome level.Mol Cell Endocrinol. 2017 Sep 15;453:14-21. doi: 10.1016/j.mce.2017.03.016. Epub 2017 Mar 16. Mol Cell Endocrinol. 2017. PMID: 28315703 Review.
-
Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):12876-81. doi: 10.1073/pnas.0403606101. Epub 2004 Aug 23. Proc Natl Acad Sci U S A. 2004. PMID: 15326291 Free PMC article.
-
25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.Mol Endocrinol. 2000 Nov;14(11):1788-96. doi: 10.1210/mend.14.11.0552. Mol Endocrinol. 2000. PMID: 11075812
-
Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.Mol Endocrinol. 1998 Sep;12(9):1367-79. doi: 10.1210/mend.12.9.0165. Mol Endocrinol. 1998. PMID: 9731705
-
The vitamin D hormone and its nuclear receptor: molecular actions and disease states.J Endocrinol. 1997 Sep;154 Suppl:S57-73. J Endocrinol. 1997. PMID: 9379138 Review.
Cited by
-
VDR restores the expression of PINK1 and BNIP3 in TECs of streptozotocin-induced diabetic mice.Life Sci Alliance. 2024 May 2;7(7):e202302474. doi: 10.26508/lsa.202302474. Print 2024 Jul. Life Sci Alliance. 2024. PMID: 38697845 Free PMC article.
-
Active vitamin D increases myogenic differentiation in C2C12 cells via a vitamin D response element on the myogenin promoter.Front Physiol. 2024 Jan 8;14:1322677. doi: 10.3389/fphys.2023.1322677. eCollection 2023. Front Physiol. 2024. PMID: 38264331 Free PMC article.
-
Is There a Role of Vitamin D in Alzheimer's Disease?CNS Neurol Disord Drug Targets. 2024;23(5):545-553. doi: 10.2174/1871527322666230526164421. CNS Neurol Disord Drug Targets. 2024. PMID: 37246320 Review.
-
Vitamin D in Neurological Diseases.Int J Mol Sci. 2022 Dec 21;24(1):87. doi: 10.3390/ijms24010087. Int J Mol Sci. 2022. PMID: 36613531 Free PMC article. Review.
-
Vitamin D and Its Target Genes.Nutrients. 2022 Mar 24;14(7):1354. doi: 10.3390/nu14071354. Nutrients. 2022. PMID: 35405966 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
